ArticleEMBO molecular medicine2020

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.

Bai-Liang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.